bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Xeris Biopharma Inc. logo

    Xeris Biopharma Inc.

    XERS | NASDAQ
    Chart Builder DCF Calculator
    $8.68
    -$0.12 (-1.36%)
    Sep 22, 2026, 11:40 AM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $1.52B
    Enterprise Value
    $1.69B
    Beta
    0.85
    Average Volume
    1.81M
    Shares Outstanding (Diluted)
    172.82M
    Shares Change YoY
    10.8%
    Institutional Ownership
    61.69%
    Exchange
    NASDAQ
    ISIN
    US98422E1038

    Price Performance

    Price Change 1M
    2.1%
    Price Change 3M
    22.2%
    Price Change 6M
    66.0%
    Price Change YTD
    19.7%
    Price Change 1Y
    12.0%
    Price Change 3Y
    388.9%
    Price Change 5Y
    253.4%
    1M CAGR (ann.)
    11.0%
    1Y CAGR (ann.)
    6.0%
    5Y CAGR (ann.)
    27.4%
    All-Time CAGR
    -9.6%

    Valuation

    PE Ratio
    -88.00
    Forward PE
    22.32
    PEG Ratio
    0.01
    Forward PEG
    0.09
    PS Ratio
    4.53
    Forward PS
    3.20
    PB Ratio
    -156.08
    P/FCF Ratio
    23.40
    P/Adj. FCF Ratio
    46.51
    P/OCF Ratio
    26.67
    EV/Sales
    5.03
    EV/EBIT
    428.81
    EV/EBITDA
    102.78
    EV/FCF
    25.98
    Earnings Yield
    -1.1%
    FCF Yield
    4.3%
    Adj. FCF Yield
    2.1%

    Financial Health

    Net Debt
    $130.84M
    Total Debt
    $289.44M
    Cash & Short-Term Investments
    $121.75M
    Total Assets
    $411.91M
    Current Ratio
    1.45
    Quick Ratio
    1.02
    Debt / Equity Ratio
    -29.74
    Debt / EBITDA
    17.63
    Debt / FCF
    4.46
    OCF / Debt
    0.23
    Interest Coverage
    1.30
    Altman Z-Score
    0.88
    Piotroski F-Score
    6

    Margins & Profitability

    Gross Profit Margin
    83.3%
    Operating Profit Margin
    10.9%
    EBITDA Margin
    4.9%
    Net Profit Margin
    -5.1%
    FCF Margin
    19.4%
    Adj. FCF Margin
    9.7%
    SBC / Revenue
    8.4%
    SBC Impact (per share)
    -49.7%

    Returns

    Return on Assets
    -4.2%
    Return on Equity
    -426.3%
    Return on Invested Capital
    12.5%
    Return on Capital Employed
    16.5%
    Return on Tangible Assets
    -5.6%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    35.8%
    Revenue CAGR 5Y
    58.3%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    66.0%
    EPS CAGR 5Y
    51.6%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    1935.6%
    FCF CAGR 5Y
    114.2%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    11
    EPS Growth Next 3Y
    333.3%
    Revenue Growth Next 3Y
    24.2%
    Earnings Date
    Nov 4, 2026
    EPS Estimate (next Q)
    $0.02
    EPS Growth Est (next Q)
    471.4%
    Revenue Est (next Q)
    $101.57M
    Revenue Growth Est (next Q)
    36.5%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $14
    Price Target Upside
    59.1%

    Cash Flow

    Operating Cash Flow
    $66.48M
    Free Cash Flow
    $64.92M
    Adj. Free Cash Flow
    $32.66M
    FCF Per Share
    $0.32
    OCF Per Share
    $0.33
    OCF/S Ratio
    16.9%

    Income Statement

    Revenue
    $335.41M
    Gross Profit
    $279.54M
    Operating Income
    $36.59M
    EBITDA
    $16.41M
    Net Income
    $-17.17M
    EPS (Diluted)
    -$0.10
    Revenue / Employee
    $771.07K
    Profit / Employee
    $-39.46K
    Employees
    435

    © 2026 bestshares.com. All rights reserved.